Cost-effectiveness of novel first-line treatment regimens for tuberculosis.
about
Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis.Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis.Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosetsThe Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.Shortened first-line TB treatment in Brazil: potential cost savings for patients and health services.Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial.Nucleoside analogs and tuberculosis: new weapons against an old enemy.2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization.Impact of Clofazimine Dosing on Treatment-Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.
P2860
Q30830344-B7DC3D06-1541-4844-854B-FE21DF91B768Q35166484-1C00A77D-11F2-46E6-973D-B91E25F20B21Q35607718-5E705900-369E-4EAC-A07A-2567A44513E7Q35745991-B4303380-ACAD-4F54-854B-E21BE330FB30Q35881727-D34E73FF-0E0F-441D-B13B-C8CF222FEBC4Q35901882-486FB792-DB61-443E-AB6F-392C1C66213DQ36115081-76B76F25-0F03-4259-A16C-B45CD55638B9Q38397331-23DA2314-8ECB-4977-B870-12454238014CQ52664543-226859D3-A33F-4A33-BE5B-66D6BAA6AF61Q53686602-A51112C2-6352-4695-93AE-B82E06BCBBD7
P2860
Cost-effectiveness of novel first-line treatment regimens for tuberculosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cost-effectiveness of novel first-line treatment regimens for tuberculosis.
@en
Cost-effectiveness of novel first-line treatment regimens for tuberculosis.
@nl
type
label
Cost-effectiveness of novel first-line treatment regimens for tuberculosis.
@en
Cost-effectiveness of novel first-line treatment regimens for tuberculosis.
@nl
prefLabel
Cost-effectiveness of novel first-line treatment regimens for tuberculosis.
@en
Cost-effectiveness of novel first-line treatment regimens for tuberculosis.
@nl
P2860
P356
P1476
Cost-effectiveness of novel first-line treatment regimens for tuberculosis
@en
P2093
P2860
P304
P356
10.5588/IJTLD.12.0776
P577
2013-05-01T00:00:00Z